InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by TARNOW MICHAEL M, Director. Officer active across 2 companies, notably Xenon Pharmaceuticals Inc.. Cumulatively, 2 filings have been recorded. The latest transaction was disclosed on 18 May 2021 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
€6,5122,057 shares@ €3.1659100.0% of flow
Common Shares
SEC:0001209191-21-034400·
€6,5122,057 shares@ €3.16590.0001% mcap50.0% of flow
Common Shares
SEC:0001209191-21-034400:0·
2 of 2 declarations
About TARNOW MICHAEL M
Michael M. Tarnow is a Director at Xenon Pharmaceuticals Inc. In this role, he participates in the governance of the company, bringing his expertise in the biopharmaceutical sector. Michael plays an active role in strategic decision-making.
